Maprotiline Side Effects

Brand Names: Ludiomil

Please note - some side effects for Maprotiline may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

Side Effects of Maprotiline - for the Consumer

Maprotiline

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Maprotiline:

Anxiety or nervousness; blurred vision; constipation; dizziness; drowsiness; dry mouth; headache; nausea; tiredness; upset stomach; weakness.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); changes in sexual function; confusion; delusions; disorientation; fast or irregular heartbeat; fainting; fever; hallucinations; involuntary movements of tongue, face, mouth, or jaw (eg, protrusion of tongue, puffing of cheeks, puckering of mouth, chewing movements), sometimes accompanied by involuntary movements of the arms and legs; lightheadedness; ringing in the ears; seizures; severe or persistent nervousness or anxiety; sore throat; tremors; trouble sleeping; trouble urinating; unusual bleeding or bruising; yellowing of the skin or eyes.

Maprotiline Side Effects - for the Professional

Maprotiline

The following adverse reactions have been noted with Maprotiline and are generally similar to those observed with tricyclic antidepressants.

Cardiovascular: Rare occurrences of hypotension, hypertension, tachycardia, palpitation, arrhythmia, heart block, and syncope have been reported with Maprotiline.

Psychiatric: Nervousness (6%), anxiety (3%), insomnia (2%), and agitation (2%); rarely, confusional states (especially in the elderly), hallucinations, disorientation, delusions, restlessness, nightmares, hypomania, mania, exacerbation of psychosis, decrease in memory, and feelings of unreality.

Neurological: Drowsiness (16%), dizziness (8%), tremor (3%), and, rarely, numbness, tingling, motor hyperactivity, akathisia, seizures, EEG alterations, tinnitus, extrapyramidal symptoms, ataxia, and dysarthria.

Anticholinergic: Dry mouth (22%), constipation (6%), and blurred vision (4%); rarely, accommodation disturbances, mydriasis, urinary retention, and delayed micturition.

Allergic: Rare instances of skin rash, petechiae, itching, photosensitization, edema, and drug fever.

Gastrointestinal: Nausea (2%) and, rarely, vomiting, epigastric distress, diarrhea, bitter taste, abdominal cramps and dysphagia.

Endocrine: Rare instances of increased or decreased libido, impotence, and elevation or depression of blood sugar levels.

Other: Weakness and fatigue (4%) and headache (4%); rarely, altered liver function, jaundice, weight loss or gain, excessive perspiration, flushing, urinary frequency, increased salivation, nasal congestion and alopecia.

Note: Although there have been only isolated reports of the following adverse reactions with Maprotiline, its pharmacologic similarity to tricyclic antidepressants requires that each reaction be considered when administering Maprotiline.

    — Bone marrow depression, including agranulocytosis, eosinophilia, purpura, and thrombocytopenia, myocardial infarction, stroke, peripheral neuropathy, sublingual adenitis, black tongue, stomatitis, paralytic ileus, gynecomastia in the male, breast enlargement and galactorrhea in the female, and testicular swelling.

Postintroduction Reports

Voluntary reports of adverse events temporally associated with Maprotiline that have been received since market introduction and that may have no casual relationship with the drug include the following: interstitial pneumonitis which were in some cases associated with eosinophilia and increased liver enzymes, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Side Effects by Body System

Gastrointestinal

Gastrointestinal side effects including dry mouth (22%), constipation (6%), and nausea (2%) have been reported. Vomiting, epigastric distress, diarrhea, bitter taste, abdominal cramps, increased salivation, and dysphagia have rarely been reported.

Nervous system

Nervous system side effects including drowsiness (16%), dizziness (8%), and tremor (3%) have been reported. Numbness, tingling, motor hyperactivity, akathisia, seizures, EEG alterations, tinnitus, extrapyramidal symptoms, ataxia, and dysarthria have rarely been reported.

Psychiatric

Psychiatric side effects including nervousness (6%), anxiety (3%), insomnia (2%), and agitation (2%) have been reported. Confusion (especially in the elderly), hallucinations, disorientation, delusions, restlessness, nightmares, hypomania, mania, exacerbation of psychosis, decrease in memory, and feelings of unreality have rarely been reported.

General

General side effects including weakness and fatigue (4%), headache (4%), and drug fever have been reported. Weight loss or gain has rarely been reported.

Ocular

Ocular side effects including blurred vision (4%) have been reported. Accommodation disturbances and mydriasis have rarely been reported.

Cardiovascular

Cardiovascular side effects including hypertension, hypotension, tachycardia, edema, arrhythmia, heart block, palpitation, and syncope have rarely been reported.

Genitourinary

Genitourinary side effects including urinary retention and delayed micturition have been reported. Urinary frequency has rarely been reported.

Dermatologic

Dermatologic side effects including skin rash, petechiae, itching, alopecia, excessive perspiration, flushing, and photosensitization have rarely been reported.

Endocrine

Endocrine side effects including increased or decreased libido, impotence, and elevation or depression of blood sugar levels have rarely been reported.

Hepatic

Hepatic side effects including altered liver function and jaundice have rarely been reported.

Respiratory

Respiratory side effects including several cases of interstitial pneumonitis have been reported. Nasal congestion has rarely been reported.

In some of the cases, the interstitial pneumonitis was associated with eosinophilia and increased liver enzymes. However, no clear causal relationship to maprotiline has been established.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.